Travere Therapeutics Provides Corporate Update and 2025 Outlook
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects net product sales for the fourth quarter of 2024 to be approximately $74 million.
View Full Press Release